Company / SG&A Expense
NP Life Sciences Health Industry Group Inc. SG&A Expense History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$165.3K
FY2023
5-year range
$100.7K / $165.3K
FY2019-FY2023
Trend
+36.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $100,673 to $165,311 over the past 2 years.
Based on SEC 10-K filings.
$165,311 in FY2023 with a 3-year CAGR of +4.2%.
Increased from $100,673 to $165,311 over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +4.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +4.2%, indicating consistent growth.
- In FY2023, sg&a expense increased 36.8% year-over-year.
- Lowest sg&a expense in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $165.3K | +36.8% |
| FY2022 | $120.9K | +20.0% |
| FY2021 | $100.7K | -31.1% |
| FY2020 | $146.1K | -3.8% |
| FY2019 | $151.9K | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026